Delivery Order SPE2DR25D1100-SPE2DR26FCS6W
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $19,227.50 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Gel-One 30 mg/3 ml syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 22, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $19,227.50 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price, non-set-aside delivery order is scheduled for completion by December 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $14,596.00. The contract represents a firm fixed price delivery order with an ultimate completion date of October 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $5,473.50. This firm fixed price delivery order, with an ultimate completion date of September 12, 2025, represents a competitive award with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $15,382.00 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on December 8, 2025, with completion expected by December 30, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,490 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 8, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating AmerisourceBergen competed against other...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,094.70. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $5,473.50 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Gel-One 30 mg/3 ml syringes. This competitive, firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $3,845.50 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on October 28, 2025, with completion targeted for November 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $18,245.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on September 22, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 14, 2025, and carries no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCS6WDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $19,227.50 and a completion date of December 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems and other federal agencies. The company's role as a prime vendor in the Defense Logistics Agency's pharmaceutical supply chain underscores its significance in fulfilling critical medical procurement needs for the Department of Defense and its beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.2k | 12/2/25 |